← All trials
NCT06809166
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 4, 2024
- Primary completion
- Jun 1, 2025
- Completion date
- Jul 31, 2025
- First posted
- Feb 5, 2025
- Last posted
- Feb 13, 2025
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- The Royal's Institute of Mental Health ResearchLead sponsor
- The Royal's Institute of Mental Health ResearchSponsor investigator
- Bausch Health CompaniesCollaborator
- University of OttawaOfficial
- University of OttawaCollaborator
- University of OttawaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.